These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25618291)

  • 1. Can the metabolic syndrome be explained by a unifying concept?
    Hjemdahl P
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):96-8. PubMed ID: 25618291
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.
    Lambert GW; Straznicky NE; Lambert EA; Dixon JB; Schlaich MP
    Pharmacol Ther; 2010 May; 126(2):159-72. PubMed ID: 20171982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic.
    Lopes HF; Egan BM
    Arq Bras Cardiol; 2006 Oct; 87(4):538-47. PubMed ID: 17128327
    [No Abstract]   [Full Text] [Related]  

  • 4. Diet and exercise in obstructive sleep apnea patients with obesity: I'll breathe to that!
    Gozal D
    Obesity (Silver Spring); 2015 Aug; 23(8):1526-7. PubMed ID: 26180039
    [No Abstract]   [Full Text] [Related]  

  • 5. Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome.
    Thorp AA; Schlaich MP
    J Diabetes Res; 2015; 2015():341583. PubMed ID: 26064978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system and the metabolic syndrome.
    Mancia G; Bousquet P; Elghozi JL; Esler M; Grassi G; Julius S; Reid J; Van Zwieten PA
    J Hypertens; 2007 May; 25(5):909-20. PubMed ID: 17414649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome.
    Lambert EA; Lambert GW
    Curr Hypertens Rep; 2011 Jun; 13(3):244-8. PubMed ID: 21271362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel Discussion: Obesity Disease and Metabolic Syndrome -from Pathophysiology to Concept of Management: Introduction].
    Matsuzawa Y; Kasuga M
    Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1626. PubMed ID: 30169922
    [No Abstract]   [Full Text] [Related]  

  • 9. The insulin resistance syndrome.
    Reaven GM
    Curr Atheroscler Rep; 2003 Sep; 5(5):364-71. PubMed ID: 12911846
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome: is there a pathophysiological common denominator?
    Tataranni PA
    World Rev Nutr Diet; 2005; 94():75-83. PubMed ID: 16145253
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome: a sympathetic disease?
    Schlaich M; Straznicky N; Lambert E; Lambert G
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):148-57. PubMed ID: 24731670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated sympathetic nerve activity: the link between low birth size and adult-onset metabolic syndrome?
    Hausberg M; Barenbrock M; Kosch M
    J Hypertens; 2004 Jun; 22(6):1087-9. PubMed ID: 15167440
    [No Abstract]   [Full Text] [Related]  

  • 13. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome: the new cardiovascular target.
    Nestel P
    Curr Opin Lipidol; 2004 Feb; 15(1):1-3. PubMed ID: 15166801
    [No Abstract]   [Full Text] [Related]  

  • 15. Gender differences in metabolic syndrome: a key research issue?
    Iyer A; Kauter K; Brown L
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):182-8. PubMed ID: 21831031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel Discussion: Approach for Pathophysiology and the Process of Establishment of Diagnostic Criteria].
    Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1627-31. PubMed ID: 30169923
    [No Abstract]   [Full Text] [Related]  

  • 17. Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects.
    Nestel PJ; Khan AA; Straznicky NE; Mellett NA; Jayawardana K; Mundra PA; Lambert GW; Meikle PJ
    Atherosclerosis; 2017 Jan; 256():21-28. PubMed ID: 27940403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point: the metabolic syndrome still lives.
    Grundy SM
    Clin Chem; 2005 Aug; 51(8):1352-4. PubMed ID: 16040840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Programs for Continuing Medical Education 2016: A Session: 4. Obesity Disease and Metabolic Syndrome: Clinical Progress and Future Outlook].
    Masuzaki H; Shimabukuro M
    Nihon Naika Gakkai Zasshi; 2017 Mar; 106(3):477-83. PubMed ID: 30182687
    [No Abstract]   [Full Text] [Related]  

  • 20. Diet and exercise improve chemoreflex sensitivity in patients with metabolic syndrome and obstructive sleep apnea.
    Maki-Nunes C; Toschi-Dias E; Cepeda FX; Rondon MU; Alves MJ; Fraga RF; Braga AM; Aguilar AM; Amaro AC; Drager LF; Lorenzi-Filho G; Negrão CE; Trombetta IC
    Obesity (Silver Spring); 2015 Aug; 23(8):1582-90. PubMed ID: 26148219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.